XRAY vs. COO: Which Stock Should Value Investors Buy Now?

Core Viewpoint - Investors in the Medical - Dental Supplies sector should consider Dentsply International (XRAY) and The Cooper Companies (COO) for potential value opportunities, with XRAY currently showing stronger metrics and analyst outlook [1][3]. Valuation Metrics - Dentsply International (XRAY) has a forward P/E ratio of 8.64, while The Cooper Companies (COO) has a forward P/E of 20.09, indicating XRAY may be undervalued [5]. - The PEG ratio for XRAY is 1.17, compared to COO's PEG ratio of 2.02, suggesting XRAY has a more favorable growth outlook relative to its valuation [5]. - XRAY's P/B ratio is 1.62, while COO's P/B ratio is 1.96, further supporting XRAY's stronger valuation metrics [6]. Analyst Outlook - XRAY holds a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision activity compared to COO, which has a Zacks Rank of 3 (Hold) [3][7]. - The improving analyst outlook for XRAY suggests it is a more attractive option for value investors at this time [3][7].